Early-onset lung cancer: etiologic heterogeneity, genomic features, and age-informed clinical management
Cancer Letters · 2026-10 · 657 · 218703
DOI: 10.1016/j.canlet.2026.218703 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2026-10. Verfasst von Yi-Zheng Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, 110001, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit nennt 95 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Early-onset lung cancer, commonly defined as disease diagnosed at or before 50 years of age, represents a growing but insufficiently characterized subset of lung cancer in clinical practice. However, much of the evidence informing current diagnostic and therapeutic practice has been generated from age-unselected or older, smoking-dominant populations and may not fully capture the clinical characteristics of younger patients. Consequently, younger individuals with lung cancer may face delayed risk recognition, incomplete molecular evaluation, and treatment decisions not fully informed by age-associated clinicobiological features. Accumulating evidence indicates that early-onset non-small cell lung cancer (NSCLC) is enriched for actionable oncogenic alterations, particularly gene fusions and selected HER2/ERBB2 alterations, and is frequently associated with lower tumor mutational burden and a less inflamed tumor microenvironment. Although these features do not yet establish early-onset NSCLC as a separate treatment category, they support age-informed refinement of guideline-based management, particularly in initial molecular testing, interpretation of immunotherapy-relevant immune features, treatment transitions, and survivorship planning. In this review, we synthesize current evidence on disease burden, etiologic heterogeneity, age-related genomic features, and treatment-relevant tumor immune context in early-onset lung cancer, with a focus on issues relevant to clinical interpretation and management prioritization. We further outline age-informed clinical management for molecular evaluation, resistance reassessment, and survivorship care, aiming to complement rather than replace established NSCLC guidelines for patients aged ≤50 years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, 110001, China.
- Department of Emergency, The First Hospital of China Medical University, No. 155 Nanjing Bei Street, Heping District, Shenyang, China.
- Clinical Medicine, China Medical University, Shenyang, China.
- State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China. Electronic address: tanghl@sysucc.org.cn.
- Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, 110001, China; Guangdong Association of Clinical Trials (GACT)/Chinese Thoracic Oncology Group (CTONG) and Guangdong Provincial K…
- Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, 110001, China. Electronic address: zhaomf618@126.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, Y. Z., Wang, Y. G., Pan, Y., Gang, X. Y., Yan, J. S., Wang, X. P., Tang, H. L., Li, H. M., & Zhao, M. F. (2026). Early-onset lung cancer: etiologic heterogeneity, genomic features, and age-informed clinical management. Cancer Letters, 657, 218703. https://doi.org/10.1016/j.canlet.2026.218703
Vancouver
Wang YZ, Wang YG, Pan Y, Gang XY, Yan JS, Wang XP, et al. Early-onset lung cancer: etiologic heterogeneity, genomic features, and age-informed clinical management. Cancer Letters. 2026;657:218703. doi:10.1016/j.canlet.2026.218703
BibTeX
@article{Wang2026,
author = {Wang, Yi-Zheng and Wang, Yue-Ge and Pan, Yue and Gang, Xiao-Yu and Yan, Jin-Shan and Wang, Xiao-Peng and Tang, Hai-Lin and Li, He-Ming and Zhao, Ming-Fang},
title = {Early-onset lung cancer: etiologic heterogeneity, genomic features, and age-informed clinical management},
journal = {Cancer Letters},
year = {2026},
volume = {657},
pages = {218703},
doi = {10.1016/j.canlet.2026.218703}
}
EUVIMED